Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · IEX Real-Time Price · USD
1.310
-0.020 (-1.50%)
At close: Jul 2, 2024, 4:00 PM
1.340
+0.030 (2.29%)
After-hours: Jul 2, 2024, 7:08 PM EDT
Unity Biotechnology Stock Forecast
UBX's stock price has decreased by -51.84% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Unity Biotechnology stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 587.02% from the current stock price of 1.31.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for UBX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 4 | 4 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 5 | 5 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +510.69% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +510.69% | Apr 16, 2024 |
Wedbush | Wedbush | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 16, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +663.36% | Nov 14, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +663.36% | Aug 9, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.84
from -2.70
EPS Next Year
-2.01
from -1.84
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 28.0M | 58.9M | 89.1M |
Avg | n/a | n/a | 26.0M | 56.7M | 85.7M |
Low | n/a | n/a | 24.3M | 55.0M | 83.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 126.8% | 57.2% |
Avg | - | - | - | 118.2% | 51.2% |
Low | - | - | - | 111.7% | 46.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.83 | -1.98 | -0.81 | 0.06 | 0.63 |
Avg | -1.84 | -2.01 | -1.12 | 0.06 | 0.61 |
Low | -1.87 | -2.05 | -1.43 | 0.06 | 0.59 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 939.6% |
Avg | - | - | - | - | 900.0% |
Low | - | - | - | - | 870.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.